Chison Medical Technologies Co., Ltd. (SHA:688358)
32.79
+0.82 (2.56%)
Jul 25, 2025, 3:00 PM CST
SHA:688358 Revenue
Chison Medical Technologies had revenue of 127.71M CNY in the quarter ending March 31, 2025, a decrease of -9.16%. This brings the company's revenue in the last twelve months to 455.81M, down -0.76% year-over-year. In the year 2024, Chison Medical Technologies had annual revenue of 468.70M, down -3.13%.
Revenue (ttm)
455.81M
Revenue Growth
-0.76%
P/S Ratio
8.05
Revenue / Employee
848.82K
Employees
537
Market Cap
3.67B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 468.70M | -15.14M | -3.13% |
Dec 31, 2023 | 483.84M | 103.00M | 27.04% |
Dec 31, 2022 | 380.84M | -16.97M | -4.27% |
Dec 31, 2021 | 397.81M | 64.72M | 19.43% |
Dec 31, 2020 | 333.09M | -36.66M | -9.92% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Sichuan Biokin Pharmaceutical | 5.82B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |